World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
24484
World Ranking
1965
National Ranking
962

Thomas M. Folks publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas M. Folks sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas M. Folks D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas M. Folks sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas M. Folks is affiliated with the Centers for Disease Control and Prevention in the United States. Their research primarily spans the field of Medicine, with focused subfields in Pathology and Forensic Medicine as well as Infectious Diseases.

The scientist's work covers several specialized topics, including:

  • Autoimmune Bullous Skin Diseases
  • Parvovirus B19 Infection Studies
  • Systemic Sclerosis and Related Diseases

Thomas M. Folks has contributed to scholarly literature with publications appearing in the venue UNC Libraries. A notable recent paper includes:

  • HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges, 2021, UNC Libraries

Their collaborative work involves frequent coauthors such as Dennis Ellenberger, Ronald A. Otten, Bin Li, Michael Aidoo, and Irma Rodriguez. Each of these collaborators appears in multiple joint contributions.

Best Publications

  • Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

    Akio Adachi;Howard E. Gendelman;Scott Koenig;Thomas Folks

  • Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

    Thomas M. Folks;Jesse Justement;Audrey Kinter;Charles A. Dinarello

  • Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

    Elia J. Duh;Wendy J. Maury;Thomas M. Folks;Anthony S. Fauci

  • Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

    Thomas M. Folks;Kathleen A. Clouse;Jesse Justement;Arnold Rabson

  • Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

    George E. Griffin;Kwanyee Leung;Thomas M. Folks;Steven Kunkel

  • The HIV 'A' (sor) gene product is essential for virus infectivity.

    Klaus Strebel;Daryl Daugherty;Kathleen Clouse;David Cohen

  • A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

    Dedra Buchwald;Paul R. Cheney;Daniel L. Peterson;Berch Henry

  • Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

    Nathan D. Wolfe;Walid Heneine;Jean K. Carr;Albert D. Garcia

  • Naturally acquired simian retrovirus infections in central African hunters

    Nathan D Wolfe;William M Switzer;Jean K Carr;Vinod B Bhullar

  • No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts

    Walid Heneine;Annika Tibell;William M Switzer;Paul Sandstrom

  • Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

    M. Berger;J. O'Shea;A. S. Cross;T. M. Folks

  • Biological and biochemical characterization of a cloned leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus

    T. M. Folks;D. Powell;M. Lightfoote;S. Koenig

  • Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

    J. Gerardo García-Lerma;Ron A. Otten;Shoukat H. Qari;Eddie Jackson

  • Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus

    T. Folks;S. Benn;A. Rabson;T. Theodore

  • Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection

    Stephen D. Lawn;Salvatore T. Butera;Thomas M. Folks

  • Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines

    Guido Poli;Jan M. Orenstein;Audrey Kinter;Thomas M. Folks

  • Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis

    Myriam Witvrouw;Christophe Pannecouque;William M Switzer;Thomas M Folks

  • Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

    Ron A. Otten;Dawn K. Smith;Debra R. Adams;Jennifer K. Pullium

  • Identification of a Human Population Infected With Simian Foamy Viruses

    Walid Heneine;William M. Switzer;Paul Sandstrom;Jennifer Brown

  • Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.

    Ronald L. Willey;Rosamond A. Rutledge;Susan Dias;Thomas Folks

  • Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges

    Shambavi Subbarao;Ronald A. Otten;Artur Ramos;Caryn Kim

  • Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.

    Henderson Dk;Saah Aj;Zak Bj;Kaslow Ra

Frequent Co-Authors

Walid Heneine
Walid Heneine Centers for Disease Control and Prevention
William M. Switzer
William M. Switzer Centers for Disease Control and Prevention
Renu B. Lal
Renu B. Lal Centers for Disease Control and Prevention
Donald S. Burke
Donald S. Burke University of Pittsburgh
Marcia L. Kalish
Marcia L. Kalish Centers for Disease Control and Prevention
Nathan D. Wolfe
Nathan D. Wolfe Global Viral
Francois Villinger
Francois Villinger University of Louisiana at Lafayette
Michael Dale Lairmore
Michael Dale Lairmore University of California, Davis
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Aftab A. Ansari
Aftab A. Ansari University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career pathways. Many students consider nursing as a complementary field, especially since it plays a critical role in patient care and clinical research.

If you’re transitioning from a non-nursing background, several reputable online absn programs for non nurses offer accelerated options to jumpstart your nursing career. These programs equip you quickly with the practical skills needed for the healthcare setting.

Additionally, accelerated nursing programs provide a streamlined path for students already holding a degree to earn their BSN without the extended timeline of traditional routes. This can be especially beneficial for immunology students seeking clinical experience.

For those interested in more entry-level nursing roles, the best easiest lpn programs to get into can provide accessible training with flexible options, allowing faster entry into the workforce while gaining foundational nursing knowledge.

To further advance your career, consider easiest online nurse practitioner programs. These offer opportunities to specialize and take on greater responsibilities, aligning well with an immunology background focused on patient care and treatment.

Exploring these related degrees can enhance your qualifications and expand your impact within health sciences and immunology-driven professions.

Best Scientists Citing Thomas M. Folks

Trending Scientists

Recently Published Articles